Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine
NCT03460405Phase 2Completed
- Sponsor
- Bio Farma
- Start
- Jul 2018
- Primary completion
- Dec 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Typhoid conjugate vaccine Vi-DT in typhoid fever, sponsored by Bio Farma. Started Jul 2018; status: completed.
02
Drugs
Typhoid conjugate vaccine Vi-DT
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT03460405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03460405.